Valuation: Biogen Inc.

Market Cap 29.82B 25.89B 24.14B 22.18B 41.94B 2,837B 42.4B 285B 111B 1,418B 112B 110B 4,698B P/E 2026 *
36.7x
P/E 2027 * 17.8x
Enterprise Value 34.9B 30.3B 28.26B 25.96B 49.09B 3,320B 49.63B 333B 130B 1,660B 131B 128B 5,499B EV / Sales 2026 *
3.35x
EV / Sales 2027 * 3.05x
Free-Float
85.97%
Yield 2026 *
-
Yield 2027 * -
1 day+2.74%
1 week+0.45%
Current month+1.77%
1 month-0.92%
3 months+10.33%
6 months+11.37%
Current year+17.36%
1 week 199.58
Extreme 199.58
218.59
1 month 186.02
Extreme 186.025
218.59
Current year 160.36
Extreme 160.3645
219.72
1 year 127
Extreme 127
219.72
3 years 110.04
Extreme 110.035
278.95
5 years 110.04
Extreme 110.035
351.86
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
9/6/26 Free

Director

1,505 0.0010%
13/2/26 Free

Head of Human Resources

8,025 0.0055%
13/2/26 Free

Executive/Senior Manager

10,560 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
+2.70%+0.45%+56.23%-23.20% 29.82B
+0.43%+9.23%+32.86%-0.92% 75.81B
+0.86%-10.75%+20.93%+180.67% 48.57B
+3.72%+47.60%+47.60%+47.60% 46.01B
+3.64%+10.69%-51.21%-51.75% 41.66B
+1.55%-7.99%+53.20%+87.89% 24.01B
+4.43%+2.88%+107.71%-46.94% 22.01B
+0.81%-2.97%-6.77%+164.33% 19.09B
+0.05%-6.56%+61.68%+115.73% 15.83B
+2.41%-4.55%+71.02%+161.31% 15.63B
Average +2.02%-0.47%+39.32%+63.47% 33.84B
Weighted average by Cap. +1.91%+1.74%+32.05%+49.09%

Financials

2026 *2027 *
Net sales 10.42B 9.05B 8.44B 7.75B 14.66B 991B 14.82B 99.48B 38.89B 496B 39.14B 38.28B 1,642B 10.62B 9.23B 8.6B 7.9B 14.94B 1,011B 15.11B 101B 39.64B 505B 39.9B 39.03B 1,674B
Net income 953M 828M 772M 709M 1.34B 90.66B 1.36B 9.1B 3.56B 45.32B 3.58B 3.5B 150B 1.9B 1.65B 1.54B 1.41B 2.67B 181B 2.7B 18.13B 7.09B 90.31B 7.13B 6.98B 299B
Net Debt 5.08B 4.41B 4.11B 3.78B 7.15B 483B 7.23B 48.5B 18.96B 242B 19.08B 18.66B 801B 2.57B 2.23B 2.08B 1.91B 3.61B 244B 3.65B 24.49B 9.57B 122B 9.64B 9.43B 404B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
05/08/26 US$206.88 +2.51% 420,608
03/08/26 US$201.82 -0.56% 940,993
31/07/26 US$202.95 -2.40% 1,062,258
30/07/26 US$207.93 -0.62% 892,938
29/07/26 US$209.23 +1.76% 2,400,174
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
201.82USD
Average target price
235.32USD
Spread / Average Target
+16.60%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock